Literature DB >> 21794951

No evidence of substantia nigra telomere shortening in Parkinson's disease.

Gavin Hudson1, David Faini, Andrea Stutt, Martin Eccles, Louise Robinson, David J Burn, Patrick F Chinnery.   

Abstract

Telomeres are repetitive tracts of DNA which protect chromosomal integrity. Increased oxidative stress leads to shorter telomeres, which have been associated with several late-onset human diseases. Given independent evidence of oxidative stress and Parkinson's disease (PD), and conflicting reports of the role of telomere length in PD, we measured telomere length in both PD peripheral blood monocytes and in substantia nigra from affected individuals and controls. We confirmed previous findings of a paradoxically longer telomere length in blood from PD patients, but found no difference in telomere length in substantia nigra. Confounding factors provide a likely explanation for the findings in blood, and possibly the reduced frequency of cigarette smoking in PD patients. We conclude that telomere shortening is unlikely to be involved in the pathogenesis of PD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21794951      PMCID: PMC4034165          DOI: 10.1016/j.neurobiolaging.2011.05.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells.

Authors:  J C Y Wang; J K Warner; N Erdmann; P M Lansdorp; L Harrington; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

2.  Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia.

Authors:  Lawrence S Honig; Nicole Schupf; Joseph H Lee; Ming X Tang; Richard Mayeux
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

3.  The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.

Authors:  Lisa Mirabello; Wen-Yi Huang; Jason Y Y Wong; Nilanjan Chatterjee; Douglas Reding; E David Crawford; Immaculata De Vivo; Richard B Hayes; Sharon A Savage
Journal:  Aging Cell       Date:  2009-06-01       Impact factor: 9.304

4.  Telomere length predicts poststroke mortality, dementia, and cognitive decline.

Authors:  Carmen Martin-Ruiz; Heather O Dickinson; Barbara Keys; Elise Rowan; Rose Anne Kenny; Thomas Von Zglinicki
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

5.  Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants.

Authors:  Raquel Moreno-Loshuertos; Rebeca Acín-Pérez; Patricio Fernández-Silva; Nieves Movilla; Acisclo Pérez-Martos; Santiago Rodriguez de Cordoba; M Esther Gallardo; José Antonio Enríquez
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

6.  A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions.

Authors:  Giuseppe De Palma; Finlay D Dick; Stefano Calzetti; Neil W Scott; Gordon J Prescott; Aileen Osborne; Neva Haites; Paola Mozzoni; Anna Negrotti; Augusto Scaglioni; Antonio Mutti
Journal:  Mov Disord       Date:  2010-05-15       Impact factor: 10.338

7.  Developmental and tissue-specific regulation of mouse telomerase and telomere length.

Authors:  K R Prowse; C W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  A percentage analysis of the telomere length in Parkinson's disease patients.

Authors:  Jing Zhi Guan; Toyoki Maeda; Masahiro Sugano; Jun-ichi Oyama; Yoshihiro Higuchi; Tomokazu Suzuki; Naoki Makino
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-05       Impact factor: 6.053

9.  Telomere length and risk of Parkinson's disease.

Authors:  Hao Wang; Honglei Chen; Xiang Gao; Monica McGrath; Dwayne Deer; Immaculata De Vivo; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

10.  Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease.

Authors:  Philip Thomas; Nathan J O' Callaghan; Michael Fenech
Journal:  Mech Ageing Dev       Date:  2008-02-01       Impact factor: 5.432

  10 in total
  17 in total

1.  Telomere length and Parkinson's disease in men: a nested case-control study.

Authors:  M Schürks; J Buring; R Dushkes; J M Gaziano; R Y L Zee; T Kurth
Journal:  Eur J Neurol       Date:  2013-09-07       Impact factor: 6.089

Review 2.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

3.  Retinal age gap as a predictive biomarker of future risk of Parkinson's disease.

Authors:  Wenyi Hu; Wei Wang; Yueye Wang; Yifan Chen; Xianwen Shang; Huan Liao; Yu Huang; Gabriella Bulloch; Shiran Zhang; Katerina Kiburg; Xueli Zhang; Shulin Tang; Honghua Yu; Xiaohong Yang; Mingguang He; Zhuoting Zhu
Journal:  Age Ageing       Date:  2022-03-01       Impact factor: 10.668

Review 4.  Age-Related Adaptive Immune Changes in Parkinson's Disease.

Authors:  Antonina Kouli; Caroline H Williams-Gray
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson's disease and Lewy body dementia.

Authors:  Muhammad Asghar; Amani Odeh; Ahmad Jouni Fattahi; Alexandra Edwards Henriksson; Aurelie Miglar; Shervin Khosousi; Per Svenningsson
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

Review 6.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

7.  Telomere length in Parkinson's disease: A meta-analysis.

Authors:  Diego A Forero; Yeimy González-Giraldo; Catalina López-Quintero; Luis J Castro-Vega; George E Barreto; George Perry
Journal:  Exp Gerontol       Date:  2016-01-07       Impact factor: 4.032

Review 8.  Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.

Authors:  George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-10-02       Impact factor: 5.590

Review 9.  Telomere shortening in neurological disorders: an abundance of unanswered questions.

Authors:  Erez Eitan; Emmette R Hutchison; Mark P Mattson
Journal:  Trends Neurosci       Date:  2014-03-31       Impact factor: 13.837

10.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.